129
Views
15
CrossRef citations to date
0
Altmetric
Research Article

The effect of formulative parameters on the size and physical stability of SLN based on “green” components

, , , , &
Pages 98-107 | Received 04 Jul 2014, Accepted 24 Sep 2014, Published online: 21 Oct 2014

References

  • Jinno J, Kamada N, Miyake M, et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Contr Rel 2006;111:56–64
  • Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int J Pharm 1998;160:229–237
  • Florence AT. The oral absorption of micro-nanoparticulates: neither exceptional nor unusual. Pharm Res 1997;14:259–266
  • Douglas S, Davies S, Illum L. Nanoparticles in drug delivery. CRC Crit Rev Ther Drug Carrier Syst 1987;4:233–261
  • Hecq J, Deleers M, Fanara D, et al. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base. Eur J Pharm Biopharm 2006;64:360–368
  • Desai MP, Labhasetwar V, Walter E, et al. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 1997;14:1568–1573
  • Caldorera-Moore M, Guimard N, Shi L, Roy K. Designer nanoparticles: incorporating size, shape, and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv 2010;7:479–495
  • Sarmento B, Martins S, Ferreira D, Souto EB. Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomed 2007;2:743–749
  • Ekambaram P, Sathali AH, Priyanka K. Solid lipid nanoparticles: a review. Sci Rev Chem Commun 2012;2:80–102
  • Kuo YC, Lin SC. Effect of glutamate on the electrical properties of cationic solid lipid nanoparticles containing stearylamine and dioctadecyldimethylammonium bromide. J Phys Chem B 2008;112:4454–4460
  • Kima BD, Naa K, Choi HK. Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan. Eur J Pharm Sci 2005;24:199–205
  • Abdelbary G, Fahmy RH. Diazepam-loaded solid lipid nanoparticles: design and characterization. AAPS PharmSciTech 2009;10:211–219
  • Siekmann B, Westesen K. Submicron-sized parenteral carrier systems based on solid lipids. Pharm Pharmacol Lett 1992;1:123–126
  • Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Delivery Rev 2012;64:83–101
  • Cavalli R, Caputo O, Marengo E, et al. The effect of the components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules. Pharmazie 1998;53:392–396
  • Souto EB, Müller RH. SLN and NLC for topical delivery of ketoconazole. J Microencapsul 2005;22:501–510
  • Kovacevic A, Savic S, Vuleta G, et al. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm 2011;406:163–172
  • Kovacevic A, Müller RH, Savic S, et al. Solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: preparation, characterization and physical stability investigation. Coll Surf A 2014;444:15–25
  • Loisel C, Keller G, Lecq G, et al. Phase transitions and polymorphism of cocoa butter J Aim Oil Chem Soc 1998;75:425–438
  • Marangoni AG, McGauley SE. Relationship between crystallization behavior and structure in cocoa butter. Cryst Growth Des 2003;3:95–108
  • Wille RL, Lutton ES. Polymorphism of cocoa butter. J Am Oil Chem Soc 1966;43:492–496
  • Garti N, Yano J. The roles of emulsifiers in fat crystallization. In: Sato K, Garti S, eds. Crystallization processes in fats and lipid systems. New York: Marcel Dekker; 2001:211–250
  • Bunjes H, Koch MH, Westesen K. Effects of surfactants on the crystallization and polymorphism of lipid nanoparticles. Progr Colloid Polym Sci 2002;121:7–10
  • Attama AA, Schicke BC, Paepenmüller T, Müller-Goymann CC. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization. Eur J Pharm Biopharm 2007;67:48–57
  • Zhang Y, Wang Z, Gemeinhart RA. Progress in microRNA delivery. J Contr Rel 2013;172:962–974
  • Qi C, Chen Y, Jing QZ, Wang XG. Preparation and characterization of catalase-loaded solid lipid nanoparticles protecting enzyme against proteolysis. Int J Mol Sci 2011;12:4282–4293
  • Xie S, Wang S, Zhao B, et al. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Coll Surf B Biointerf 2008;67:199–204
  • Patil Y, Panyam J. Polymeric nanoparticles for siRNA delivery and gene silencing. Int J Pharm 2009;367:195–203
  • Delie F, Berton M, Allémann E, Gurny R. Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles. Int J Pharm 2001;214:25–30
  • Anchisi C, Maccioni AM, Sinico C, Valenti D. Stability studies of new cosmetic formulations with vegetable extracts as functional agents. Il Farmaco 2001;56:427–431
  • Schwarz C, Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm 1997;157:171–179
  • Zimmerman E, Muller RH, Mader K. Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharm 2000;196:211–213
  • Cavalli R, Caputo O, Carlotti ME, et al. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int J Pharm 1997;148:47–54
  • Spada G, Gavini E, Cossu M, et al. Solid lipid nanoparticles with and without hydroxypropyl-β-cyclodextrin: a comparative study of nanoparticles designed for colonic drug delivery. Nanotechnology 2012;23:095101
  • Mosmann TR. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Meth 1983;65:55–63
  • Hilgers AR, Conradi RA, Burton PS. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res 1990;7:902–910
  • Anarjan N, Tan CP, Nehdi IA, Ling TC. Colloidal astaxanthin: preparation, characterisation and bioavailability evaluation. Food Chem 2012;135:1303–1309
  • Spada G, Gavini E, Sorrenti M, et al. Evaluation of chemical influences on protein-polymeric nanoparticles adsorption process. Curr Nanosci 2012;8:819–829
  • Bittner B, Morlock M, Koll H, et al. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. Eur J Pharm Biopharm 1998;45:295–305
  • Müller RH. Zetapotential und partikelladung – kurzetheorie, praktische meβdurchfuhrung, dateninterpretation. Stuttgart: WissenschaftlicheVerlagsgesellschaft; 1996
  • Schenk H, Peschar R. Understanding the structure of chocolate. Radiat Phys Chem 2004;71:829–835
  • Guthrie SE, Mazzanti G, Idziak SH. X-ray phase identification of chocolate is possible without the removal of sugar. Eur J Lipid Sci Technol 2005;107:656–659
  • Van Langevelde A, Van Malssen K, Peschar R, Schenk H. Effect of temperature on recrystallization behavior of cocoa butter. J Am Oil Chem Soc 2001;78:919–925
  • Xiao-Yan L, Xia W, Deng-Guang Y, et al. Electrospun borneol-PVP nanocomposites. J Nanomater 2012;8: Article ID 731382
  • Doktorovova S, Souto EB, Silva AM. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – a systematic review of in vitro data. Eur J Pharm Biopharm 2014;87:1–18
  • Gavini E, Spada G, Rassu G, et al. Development of solid nanoparticles based on hydroxypropyl-β-cyclodextrin aimed for the colonic transmucosal delivery of diclofenac sodium. J Pharm Pharmacol 2011;63:472–482
  • Arechabala B, Coiffard C, Rivalland P, et al. Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release. J Appl Toxicol 1999;19:163–165
  • Muller RH, Ruhl D, Runge S, et al. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res 1997;14:458–462
  • Geys J, Nemery B, Hoet PHM. Assay conditions can influence the outcome of cytotoxicity tests of nanomaterials: better assay characterization is needed to compare studies. Toxicol In Vitro 2010;24:620–629
  • Fernandez P, Andre V, Rieger J, Kuhnle A. Nanoemulsions formation by emulsions phase inversion. Colloid Surface A 2004;251:53–58
  • Ee SL, Duan X, Liew J, Nguyen QD. Droplet size and stability of nanoemulsions produced by temperature phase inversion method. Chem Eng J 2008;140:626–663
  • Gattefossé. Emulium kappa2 brochure. Available from: http://www.alfa-chemicals.co.uk/Libraries/Personal_Care_brochures/Emulium_Kappa_2_Brochure.sflb.ashx. [last accessed 9 Oct 2014]
  • Sanna V, Kirschvink N, Gustin P, et al. Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS Pharm Sci Tech 2004;5:17–23
  • Product Integrity Philip Morris USA. Evaluation of cocoa for use as a cigarette ingredient. Available from: http://legacy.library.ucsf.edu/tid/wcc34a00/pdf [last accessed 26 May 2014]
  • Ujhelyi Z, Fenyvesi F, Váradi J, et al. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer. Eur J Pharm Sci 2012;47:564–573

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.